FDA Press Office Shakeup Startles Ousted Staffers
This article was originally published in The Tan Sheet
Executive SummaryA young FDA official's decision to boot three seasoned press specialists from the Public Affairs Office may be an embarrassment for the agency.
You may also be interested in...
Novartis co-leads industry forum on preapproval access that aims to share best practices and engage patient groups; Janssen is launching three pilots to leverage collection of preapproval access data.
FDA is worried about drug names that could appear to overstate efficacy and impact consumer and healthcare provider perceptions of the product.